查詢結果分析
相關文獻
- In Vitro Stability Evaluation of Rhenium-188-MAG[feb0]: A Potential Therapeutic Agent for Prevention of Restenosis after Percutaneous Transluminal Coronary Angioplasty
- 添加不同種類寡醣對番石榴果漿品質之影響
- 維生素C、E與自由基對運動表現的交互影響
- Effect of Ascorbic Acid on Mouse Plasma Fibronectin Concentration
- 補充維生素E和C對犢牛免疫之影響
- 維生素C在家禽飼料上抗緊迫之效果
- 水果在家庭式貯存過程中糖份、酸度及維生素C 含量變化之比較研究
- L-抗壞血酸基-2-多聚磷酸鹽用作隔離斷奶仔豬和常規斷奶仔豬之維生素C來源
- 新世代新寵--大人、小孩都愛的維生素C
- 談維生素C對皮膚的作用
頁籤選單縮合
題 名 | In Vitro Stability Evaluation of Rhenium-188-MAG[feb0]: A Potential Therapeutic Agent for Prevention of Restenosis after Percutaneous Transluminal Coronary Angioplasty=冠狀動脈擴張術後預防再狹症治療劑錸-188-MAG[feb0]體外安定性研究 |
---|---|
作 者 | Wang,Theodore S. T.; Weinberger,Judith; Fawwaz,Rashid A.; Van Heertum,Ronald L.; | 書刊名 | 核子醫學雜誌 |
卷 期 | 14:1 2001.03[民90.03] |
頁 次 | 頁19-25 |
分類號 | 418.22 |
關鍵詞 | 錸-188-MAG[feb0]; 體外安定性; 維生素C; 龍膽酸; 188Re-MAG[feb0]; Restenosis; In vitro stability; Ascorbic acid; Gentisic acid; |
語 文 | 英文(English) |
中文摘要 | 背景:實施冠狀動脈擴張手術後之病人超過30%會發生心血管再狹症。利用錸-188-MAG3配合汽球擴張術對血管狹窄處進行局部輻射照射以預防再狹症復發,目前正進行IND試驗中。汽球破裂為這項治療可能發生的顧慮。本研究目的為評估錸-188-MAG3的放射化學安定性。萬一發生汽球破裂時,穩定的錸-188-MAG3會很快由腎臟排泄,確保全身輻射劑量低於可接受範圍。不安定的錸-188-MAG3則會使放射活性停滯在許多器官,對病人造成較高的輻射劑量。 方法:製備完成的錸-188-MAG3(3.7 GBq/ml)分成五組:包括控制組(不含維生素C或龍膽酸)、含25mg維生素C、含50mg維生素、含1 mg龍膽酸、含2 mg龍膽酸等;所有樣品均保存室溫下。每一樣品的體外安定性都以ITLC-SG/生理鹽水、TLC-SG 60/acetonitrile及Sep-Pak C18管柱(分別以0.001N HCI及乙醇-生理鹽水混合液淘洗)等分析系統在製備後0、3、6及24小時分析。 結果:控制組樣品的平圾放射化學純度在製備後3小時由原來的97%降為80%;6小時降為59%;24小時降為4%。樣品中含維生素C 25 mg或50 mg,錸-188-MAG3製備後24 小時的放射化學純度仍可以完整保留。樣品中若含龍膽酸1 mg或2 mg,錸-188-MAG3的放射化學純度可以保存至少6小時。 |
英文摘要 | Backgrounds: following coronary angioplasty restenosis occurs in≧30% of cases. Local irradiation of the stenosed artery immediately after angioplasty using 188Re-MAG3 delivered into the diseased vessel via a balloon to prevent the restenosis is currently under investigation (IND). A potential complication of the procedure is balloon rupture. The aim of this study is to evaluate the radiochemical stability of 188Re-MAG3. stable 188 Re-MAG3, in unlikely event of balloon rupture, will be quickly eliminated via the kidneys, with a resultant acceptability low whole body radiation does. Unstable 188Re-MAG3, which is retained in various organs results in a greater rediation burden to the patient. Methods: 188Re-MAG3 (3.7 GBq/ml) was prepared, and the product was evenly divided into 5 sample groups: control (without ascorbic or gentisic acid), with 25 mg of ascorbic acid, with 50 mg of ascorbic acid, with 1 mg of gentisic acid, and with 2 mg of gentisic acid. The samples were kept at room temperature. The in vitro stability of each sample was analyzed (N=3) by using ITLCSG/normal saline, TLC-SG 60/caetonitrile, and sep-Pak C18 column/ 0.001 N HCI, ethano/normal saline systems at 0, 3, 6 and 24 h after preparation. Results: The results demonstrated that the mean radiochemical purity of the control sample decreased from 97% to 80% at 3 h, to 59% at 6 h, and to 4% at 24 h after preparation. In the presence of either 25 mg or 50 mg of ascorbic acid, the stability of 188Re-MAG3 was fully preserved after 24 h. in the presence of 1 mg or 2 mg of gentisic acid, the stability of 188Re-MAG3 was fully preserved up to 6 h after preparation. Conclusion: The presence of ascorbic acid (25~50 mg) is needed to maintain in vitro stability of 188Re-MAG3. |
本系統中英文摘要資訊取自各篇刊載內容。